.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Mallinckrodt
Dow
Daiichi Sankyo
Farmers Insurance
Colorcon
McKinsey
Baxter
Novartis
Julphar
AstraZeneca

Generated: September 20, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 088508

« Back to Dashboard
NDA 088508 describes TUSSIGON, which is a drug marketed by King Pharms and is included in one NDA. It is available from one supplier. Additional details are available on the TUSSIGON profile page.

The generic ingredient in TUSSIGON is homatropine methylbromide; hydrocodone bitartrate. There are five drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the homatropine methylbromide; hydrocodone bitartrate profile page.

Summary for NDA: 088508

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 088508

Mechanism of ActionOpioid Agonists

Suppliers and Packaging for NDA: 088508

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TUSSIGON
homatropine methylbromide; hydrocodone bitartrate
TABLET;ORAL 088508 ANDA Pfizer Laboratories Div Pfizer Inc 61570-102 61570-102-01 100 TABLET in 1 BOTTLE (61570-102-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength1.5MG;5MG
Approval Date:Jul 30, 1985TE:AARLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Cantor Fitzgerald
Novartis
Chinese Patent Office
US Army
Express Scripts
UBS
Citi
Dow
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot